Skip to content

WellSky Transfusion 2022Recalls & reported problems

Wellsky Corporation · WellSky Transfusion 2022 is a Blood Establishment Computer Software Product. Other than the packaging material/labeling. There is no hardware or other components included in the final product.WellSky Transfusion 2022 is intended to address all phases of transfusion services activities, and assists transfusion service personnel: • Manipulate and label products • Print ISBT 128 blood labels • Perform electronic cross match • Issue blood products under normal and emergency conditions • Receive and test patient and unit specimens • Interface to blood bank testing instruments (bi-directional) • Interface to blood storage device (bidirectional) WellSky Transfusion 2022 provides customized control processes for transfusion management of all procedures and testing on products and patients to reduce human error and enhance the ability to assure patient and product safety. · Class 2

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI B105TRANSFUSION0), received between Oct 4, 2024 and Oct 4, 2024 — classified as 1 malfunction.

The most frequently reported specific device problem is “Data Problem” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 1 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Data Problem1

Patient problems

  • No Clinical Signs, Symptoms or Conditions1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionOct 4, 2024Data Problem; Data Problem

    ON SEPTEMBER 6, 2024, WELLSKY WAS NOTIFIED BY A THIRD PARTY OF A CALCULATION ISSUE WITH THE WELLSKY TRANSFUSION SOFTWARE. THIS ISSUE Y OCCURS WHEN THE BLOOD BANK'S SOFTWARE ADMINISTRATOR ("THE ADMINISTRATOR") CONFIGURES THE SYSTEM TO CALCULATE THE COLLECTION DATE FOR MODIFIED OR POOLED PRODUCTS. WHILE THE SOFTWARE FUNCTIONED AS DESIGNED, THE CONFIGURATION SET BY THE ADMINISTRATOR CAUSED THE COLLECTION DATE TO BE CALCULATED INCORRECTLY. THE ADMINISTRATOR HAD CONFIGURED THE SOFTWARE TO CALCULATE THE COLLECTION DATE FOR IRRADIATED RED BLOOD CELLS 28 DAYS PRIOR TO THE KNOWN EXPIRATION DATE. THIS CONFIGURATION CAUSED THE SOFTWARE TO DISPLAY AN INACCURATE COLLECTION DATE TO END USERS, WHICH CAN BE IMPORTANT INFORMATION FOR IMMUNOCOMPROMISED, NEONATAL, OR AT-RISK PATIENTS BASED ON PHYSICIAN ORDER OR BLOOD CENTER STANDARD OPERATING PROCEDURES. THE DISPLAY OF INACCURATE COLLECTION DATES COULD MISLEAD THE END USER ABOUT THE TRUE AGE OF THE PRODUCT. WHILE NO ADVERSE EVENTS HAVE BEEN ASSOCIATED WITH THIS INCIDENT, THE TRANSFUSION OF BLOOD PRODUCTS THAT EXCEED THE SPECIFIED AGE REQUIREMENTS FOR AT-RISK PATIENTS COULD POTENTIALLY HAVE NEGATIVE RESULTS. PROPER CONFIGURATION, IN ACCORDANCE WITH IN

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 20375996 ↗

Other Blood Establishment Computer Software And Accessories devices

All Blood Establishment Computer Software And Accessories devices →

Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.